Investor Relations

Investors

Solventum Issues 2025 Year-End Shareholder Letter: Reflection on a Year of Growth and Transformation

Company Overview

A new healthcare company with a rich history

With more than 70 years of delivering healthcare innovations, we continue to move the industry forward by helping to solve our customers’ biggest challenges.

  • $8.3 billion in sales in 2024
  • 20,000+ professionals shaping the future of health

Latest Sustainability Report

For Fiscal Year Ending Dec 31, 2024

View Report

IR Contacts

Headquarters

Solventum Corporation
2510 Conway Avenue East
3M Center, Building 275-6W
Maplewood, MN 55144

Investor Relations

investors@solventum.com

Transfer Agent

EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
T: 651-450-4064
https://www.shareowneronline.com